D
Arcturus Therapeutics Holdings Inc. ARCT
$18.51 $1.035.89% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -25.47% 15.38% -8.69% -45.85% -38.04%
Total Other Revenue -- -- -- -- --
Total Revenue -25.47% 15.38% -8.69% -45.85% -38.04%
Cost of Revenue -16.83% -15.74% -1.63% 0.10% 21.19%
Gross Profit -94.58% 204.93% -51.49% -83.59% -87.37%
SG&A Expenses -10.82% -8.66% -0.09% 1.39% 3.34%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -23.04% -8.93% 1.21% 2.65% 14.77%
Operating Income 18.57% 33.47% -22.33% -230.93% -302.43%
Income Before Tax 14.46% 34.82% -190.23% -161.04% -185.81%
Income Tax Expenses -115.80% -117.67% -100.16% -90.83% -30.48%
Earnings from Continuing Operations 16.39% 36.44% -172.30% -163.07% -189.63%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 16.39% 36.44% -172.30% -163.07% -189.63%
EBIT 18.57% 33.47% -22.33% -230.93% -302.43%
EBITDA 19.15% 34.51% -22.43% -219.93% -284.99%
EPS Basic 17.20% 37.31% -168.80% -162.16% -188.73%
Normalized Basic EPS 15.28% 35.71% -29.06% -189.99% -244.50%
EPS Diluted 17.23% 37.31% -158.58% -164.50% -192.83%
Normalized Diluted EPS 15.28% 35.71% -28.28% -193.95% -253.66%
Average Basic Shares Outstanding 1.17% 1.40% 1.49% 1.26% 0.90%
Average Diluted Shares Outstanding 1.17% 1.40% 0.93% 0.16% -0.20%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --